e-ISSN 1309-2545      ISSN 1301-062X
TR    ENG
 

Download Current Issue.

Volume : 24 Issue : 4 Year : 2018

Current Issue Archive Popular Articles Ahead of Print Submit Your Article Login
Turkish Journal of Neurology Indexed By
 
  Search






Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years [Turk J Neurol]
Turk J Neurol. 2018; 24(3): 203-215 | DOI: 10.4274/tnd.79836  

Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

Nefati Kıylıoğlu
Adnan Menderes University Faculty of Medicine, Department of Neurology, Division of Clinical Neurophysiology, Aydın, Turkey

With the advent of new agents in the treatment of multiple sclerosis, new treatment modalities have emerged (escalation-induction therapy) and the increased efficacy of the drugs has led to increased drug-related risks. The risk/benefit balance has become more carefully assessed. The increased need for reliable markers to predict prognosis-disability has also led to an increase in research conducted in this area. In this short review, studies published between 2012-2017, especially those related to prognosis and disability, were compiled.

Keywords: Multiple sclerosis, disability, prognosis, biomarker


Nefati Kıylıoğlu. Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years. Turk J Neurol. 2018; 24(3): 203-215

Corresponding Author: Nefati Kıylıoğlu, Türkiye


TOOLS
English Full Text
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
© Copyright 2018 Turkish Journal of Neurology
Home        |        Contact
LookUs & OnlineMakale